BAP1 loss defines a new class of renal cell carcinoma

Overview of attention for article published in Nature Genetics, June 2012

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 3 news outlets
twitter: 20 X users

patent: 9 patents
guideline: 1 clinical guideline source

Readers on

mendeley: 397 Mendeley
citeulike: 4 CiteULike

So far, Altmetric has seen 9 patents that reference this research output.

CANCER THERAPY

Application WO-2023233148-A1

World Intellectual Property Organisation (WIPO)

07 Dec 2023

Methods for sensitizing cancer cells to T cell-mediated killing by modulating molecular…

Grant US-11820822-B2

United States of America

21 Nov 2023

METHODS AND COMPOSITIONS FOR CLASSIFYING AND TREATING KIDNEY CANCER

Application WO-2023080900-A1

World Intellectual Property Organisation (WIPO)

11 May 2023

METHOD FOR DETERMINING RCC SUBTYPES

Application WO-2020207685-A1

World Intellectual Property Organisation (WIPO)

15 Oct 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 5 additional patents.